Cowen and Company’s Johnson & Johnson JNJ Stock Holding History

Cowen and Company’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-37,500	Closed	-$5.84M	–	640
2023 Q3	$5.84M	Buy	+37,500	New	+$6.19M	0.41%	53
2022 Q1	–	Sell	-8,574	Closed	-$1.47M	–	673
2021 Q4	$1.47M	Buy	+8,574	New	+$1.4M	0.13%	139

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cowen and Company's JNJ Position: Q4 2023 in Review

Cowen and Company sold out of Johnson & Johnson (JNJ) in Q4 2023, closing a stake of 37,500 shares — an estimated $5.84M sold.

Cowen and Company first reported a position in JNJ in Q4 2021 and held it in 2 quarters. The position peaked at $5.84M in Q3 2023. 3,869 funds tracked by Wall St. Rank hold JNJ as of Q4 2023.

Cowen and Company reported no remaining Johnson & Johnson position as of Q4 2023 after selling out during the quarter.
Cowen and Company sold 37,500 Johnson & Johnson shares in Q4 2023, an estimated $5.84M.
Cowen and Company first reported a position in Johnson & Johnson in Q4 2021 and held it in 2 quarters.
Cowen and Company's Johnson & Johnson position peaked at $5.84M in Q3 2023.
3,869 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2023.

Based on Cowen and Company's 13F filing for Q4 2023, filed 8 Feb 2024.